Literature DB >> 20511229

Fragrant dioxane derivatives identify beta1-subunit-containing GABAA receptors.

Olga A Sergeeva1, Olaf Kletke, Andrea Kragler, Anja Poppek, Wiebke Fleischer, Stephan R Schubring, Boris Görg, Helmut L Haas, Xin-Ran Zhu, Hermann Lübbert, Günter Gisselmann, Hanns Hatt.   

Abstract

Nineteen GABA(A) receptor (GABA(A)R) subunits are known in mammals with only a restricted number of functionally identified native combinations. The physiological role of beta1-subunit-containing GABA(A)Rs is unknown. Here we report the discovery of a new structural class of GABA(A)R positive modulators with unique beta1-subunit selectivity: fragrant dioxane derivatives (FDD). At heterologously expressed alpha1betaxgamma2L (x-for 1,2,3) GABA(A)R FDD were 6 times more potent at beta1- versus beta2- and beta3-containing receptors. Serine at position 265 was essential for the high sensitivity of the beta1-subunit to FDD and the beta1N286W mutation nearly abolished modulation; vice versa the mutation beta3N265S shifted FDD sensitivity toward the beta1-type. In posterior hypothalamic neurons controlling wakefulness GABA-mediated whole-cell responses and GABAergic synaptic currents were highly sensitive to FDD, in contrast to beta1-negative cerebellar Purkinje neurons. Immunostaining for the beta1-subunit and the potency of FDD to modulate GABA responses in cultured hypothalamic neurons was drastically diminished by beta1-siRNA treatment. In conclusion, with the help of FDDs we reveal a functional expression of beta1-containing GABA(A)Rs in the hypothalamus, offering a new tool for studies on the functional diversity of native GABA(A)Rs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20511229      PMCID: PMC2911342          DOI: 10.1074/jbc.M110.103309

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit.

Authors:  Rachel Jurd; Margarete Arras; Sachar Lambert; Berthold Drexler; Roberta Siegwart; Florence Crestani; Michael Zaugg; Kaspar E Vogt; Birgit Ledermann; Bernd Antkowiak; Uwe Rudolph
Journal:  FASEB J       Date:  2002-12-03       Impact factor: 5.191

2.  GABA(A) receptor heterogeneity in histaminergic neurons.

Authors:  Olga A Sergeeva; Krister S Eriksson; Irina N Sharonova; Vladimir S Vorobjev; Helmut L Haas
Journal:  Eur J Neurosci       Date:  2002-10       Impact factor: 3.386

3.  Zinc-mediated inhibition of GABA(A) receptors: discrete binding sites underlie subtype specificity.

Authors:  Alastair M Hosie; Emma L Dunne; Robert J Harvey; Trevor G Smart
Journal:  Nat Neurosci       Date:  2003-04       Impact factor: 24.884

4.  Forced subunit assembly in alpha1beta2gamma2 GABAA receptors. Insight into the absolute arrangement.

Authors:  Sabine W Baumann; Roland Baur; Erwin Sigel
Journal:  J Biol Chem       Date:  2002-09-24       Impact factor: 5.157

5.  Fishing for allosteric sites on GABA(A) receptors.

Authors:  Richard W Olsen; Chang-Sheng S Chang; Guodong Li; H Jacob Hanchar; Martin Wallner
Journal:  Biochem Pharmacol       Date:  2004-10-15       Impact factor: 5.858

Review 6.  Mapping of the benzodiazepine recognition site on GABA(A) receptors.

Authors:  Erwin Sigel
Journal:  Curr Top Med Chem       Date:  2002-08       Impact factor: 3.295

7.  Salicylidene salicylhydrazide, a selective inhibitor of beta 1-containing GABAA receptors.

Authors:  S A Thompson; L Wheat; N A Brown; P B Wingrove; G V Pillai; P J Whiting; C Adkins; C H Woodward; A J Smith; P B Simpson; I Collins; K A Wafford
Journal:  Br J Pharmacol       Date:  2004-04-20       Impact factor: 8.739

8.  Inhibitory transmission in locus coeruleus neurons expressing GABAA receptor epsilon subunit has a number of unique properties.

Authors:  P Belujon; J Baufreton; L Grandoso; E Boué-Grabot; T F C Batten; L Ugedo; M Garret; A I Taupignon
Journal:  J Neurophysiol       Date:  2009-07-22       Impact factor: 2.714

Review 9.  The benzodiazepine site of the GABAA receptor: an old target with new potential?

Authors:  Alan N Bateson
Journal:  Sleep Med       Date:  2004-06       Impact factor: 3.492

Review 10.  Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics.

Authors:  Uwe Rudolph; Hanns Möhler
Journal:  Annu Rev Pharmacol Toxicol       Date:  2004       Impact factor: 13.820

View more
  22 in total

Review 1.  A novel GABA(A) receptor pharmacology: drugs interacting with the α(+) β(-) interface.

Authors:  Werner Sieghart; Joachim Ramerstorfer; Isabella Sarto-Jackson; Zdravko Varagic; Margot Ernst
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  GABAA receptors involved in sleep and anaesthesia: β1- versus β3-containing assemblies.

Authors:  Yevgenij Yanovsky; Stephan Schubring; Wiebke Fleischer; Günter Gisselmann; Xin-Ran Zhu; Hermann Lübbert; Hanns Hatt; Uwe Rudolph; Helmut L Haas; Olga A Sergeeva
Journal:  Pflugers Arch       Date:  2011-07-07       Impact factor: 3.657

3.  Benzodiazepine-site pharmacology on GABAA receptors in histaminergic neurons.

Authors:  A C May; W Fleischer; O Kletke; H L Haas; O A Sergeeva
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

4.  α4βδ GABA(A) receptors are high-affinity targets for γ-hydroxybutyric acid (GHB).

Authors:  Nathan Absalom; Laura F Eghorn; Inge S Villumsen; Nasiara Karim; Tina Bay; Jesper V Olsen; Gitte M Knudsen; Hans Bräuner-Osborne; Bente Frølund; Rasmus P Clausen; Mary Chebib; Petrine Wellendorph
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

5.  L-Dopa activates histaminergic neurons.

Authors:  Yevgenij Yanovsky; Sha Li; Boris P Klyuch; Qiaoling Yao; Patrizio Blandina; M Beatrice Passani; Jian-Sheng Lin; Helmut L Haas; Olga A Sergeeva
Journal:  J Physiol       Date:  2011-01-17       Impact factor: 5.182

6.  Alterations in Purkinje cell GABAA receptor pharmacology following oxygen and glucose deprivation and cerebral ischemia reveal novel contribution of β1 -subunit-containing receptors.

Authors:  Melissa H Kelley; Justin Ortiz; Kaori Shimizu; Himmat Grewal; Nidia Quillinan; Paco S Herson
Journal:  Eur J Neurosci       Date:  2012-11-26       Impact factor: 3.386

7.  Proton- and ammonium-sensing by histaminergic neurons controlling wakefulness.

Authors:  Yevgenij Yanovsky; Jeffrey M Zigman; Anna Kernder; Alisa Bein; Ichiro Sakata; Sherri Osborne-Lawrence; Helmut L Haas; Olga A Sergeeva
Journal:  Front Syst Neurosci       Date:  2012-04-13

8.  GABAergic inhibition of histaminergic neurons regulates active waking but not the sleep-wake switch or propofol-induced loss of consciousness.

Authors:  Anna Y Zecharia; Xiao Yu; Thomas Götz; Zhiwen Ye; David R Carr; Peer Wulff; Bernhard Bettler; Alexei L Vyssotski; Stephen G Brickley; Nicholas P Franks; William Wisden
Journal:  J Neurosci       Date:  2012-09-19       Impact factor: 6.167

9.  Waking action of ursodeoxycholic acid (UDCA) involves histamine and GABAA receptor block.

Authors:  Yevgenij Yanovsky; Stephan R Schubring; Quiaoling Yao; Yan Zhao; Sha Li; Andrea May; Helmut L Haas; Jian-Sheng Lin; Olga A Sergeeva
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

10.  Partial agonism of taurine at gamma-containing native and recombinant GABAA receptors.

Authors:  Olaf Kletke; Guenter Gisselmann; Andrea May; Hanns Hatt; Olga A Sergeeva
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.